4FE-21710-99389 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-19
Dose 1 — Pfizer-BioNTech
2021-02-08
Dose 2 — Pfizer-BioNTech
2021-02-28
Registered in v-safe
2021-02-28
Survey response — day 14, dose 2
MedDRA: Headache, Pain, Pyrexia — Feeling: Good · Be unable to work, Be unable to do your normal daily activities

Free text: Headache, body aches, fever 100.3F

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-28
Report sent to call center — day 14, dose 2
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-03-03
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-08-09
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-09-28
Dose 3 — Pfizer-BioNTech
2021-09-28
Health check-in — day 0, dose 3
Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-09-29
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · None

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-19	Pfizer-BioNTech
2	2021-02-08	Pfizer-BioNTech
3	2021-09-28	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-02-28	priority 2/3

Free text

Release 4 — day 14, dose 2

2021-02-28

Symptoms: Headache, body aches, fever 100.3F

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Headache	✓	✓	✓
SD	Pain	✓	✓	✓
SD	Pyrexia	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release